Prostaglandins are important molecules involved in inflammation and immunomodulation. The rate-limiting step in the synthesis of these potent mediators is the expression of the enzyme cyclo-oxygenase (COX). The isoform responsible, COX-2, is encoded by an immediate-early gene induced by various pro-inflammatory agents in macrophages. Selective blockade of COX-2 by the use of an antisense strategy would overcome the undesirable side effects of conventional inhibitors. Here we describe cellular internalization and activity of a novel class of oligonucleotide analogues named peptide nucleic acids (PNAs) as inhibitors of COX-2 translation. In particular, we designed two antisense murine COX-2 PNA molecules, directed against a mRNA region spanning the AUG translation-initiation codon and a homopurinic sequence inside the COX-2 mRNA reading frame. These two PNA sequences, used separately or mixed together, demonstrated the capacity to inhibit the translation of murine COX-2 enzyme in a cell-free translation model using a rabbit retculocyte lysate model. Since PNAs display very low natural permeability across lipids bilayers, the two molecules were also re-synthesized, modified to be used in intact cells by means of linkage to a hydrophobic peptide to obtain membrane-diffusable PNA chimaerae. Finally, stimulated macrophages were found to be affected strongly by these two compounds, used separately or together, monitoring inhibition of COX-2 synthesis by Western blot analysis of total lysates and enzymic activity via radioactive assay on the microsomal fractions.